| Dr Colleen Mary Horan, MD | |
|
130 Fisher Rd, Mob-a, Suite 1-4, Berlin, VT 05602-9516 | |
| (802) 371-5961 | |
| (802) 371-5960 |
| Full Name | Dr Colleen Mary Horan |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 23 Years |
| Location | 130 Fisher Rd, Berlin, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821017583 | NPI | - | NPPES |
| 1019449 | Medicaid | VT | |
| 0074411 | Medicaid | NJ | |
| 101331510 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD425579 (Pennsylvania) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 0420012252 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Vermont Medical Center | Barre, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Vermont Medical Center Inc | 9335138817 | 204 |
News Archive
A project to create a common platform throughout Europe for researchers working in the field of ‘biological crystallography' is underway thanks to a grant of 10 million euros from the EU's 6th Framework Programme (FP6).
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Quarraisha Abdool Karim has spent the past three decades studying HIV and AIDS. She has become one of the world's leading epidemiologists and made major contributions to the global understanding of how HIV affects young women.
Limited health literacy can lead to difficulties in patients' self-care activities such as taking prescribed medications. Since a considerable amount of health information changes hands in the pharmacy setting, research by pharmacists into evaluating which tools are effective in practice can make a valuable contribution to goals set by the 2010 US National Action Plan to Improve Health Literacy and lead to improvements in communications and health care, say experts in this special themed issue on "Pharmacy, Medication Use, and the National Action Plan to Improve Health Literacy," published in the journal Research in Social and Administrative Pharmacy.
Artemisinin-based combination therapies (ACTs) are the currently recommended drugs for treating malaria. However, they are expensive, which limits their affordability. This means that people with malaria are likely to buy cheaper, less effective antimalarials such as chloroquine and sulphadoxine-pyrimethamine; or to simply buy painkillers and antipyretics.
› Verified 2 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
A project to create a common platform throughout Europe for researchers working in the field of ‘biological crystallography' is underway thanks to a grant of 10 million euros from the EU's 6th Framework Programme (FP6).
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Quarraisha Abdool Karim has spent the past three decades studying HIV and AIDS. She has become one of the world's leading epidemiologists and made major contributions to the global understanding of how HIV affects young women.
Limited health literacy can lead to difficulties in patients' self-care activities such as taking prescribed medications. Since a considerable amount of health information changes hands in the pharmacy setting, research by pharmacists into evaluating which tools are effective in practice can make a valuable contribution to goals set by the 2010 US National Action Plan to Improve Health Literacy and lead to improvements in communications and health care, say experts in this special themed issue on "Pharmacy, Medication Use, and the National Action Plan to Improve Health Literacy," published in the journal Research in Social and Administrative Pharmacy.
Artemisinin-based combination therapies (ACTs) are the currently recommended drugs for treating malaria. However, they are expensive, which limits their affordability. This means that people with malaria are likely to buy cheaper, less effective antimalarials such as chloroquine and sulphadoxine-pyrimethamine; or to simply buy painkillers and antipyretics.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Colleen Mary Horan, MD Po Box 547, Att: Cvmc Finance Department, Barre, VT 05641-0547 Ph: (802) 371-5961 | Dr Colleen Mary Horan, MD 130 Fisher Rd, Mob-a, Suite 1-4, Berlin, VT 05602-9516 Ph: (802) 371-5961 |
News Archive
A project to create a common platform throughout Europe for researchers working in the field of ‘biological crystallography' is underway thanks to a grant of 10 million euros from the EU's 6th Framework Programme (FP6).
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Quarraisha Abdool Karim has spent the past three decades studying HIV and AIDS. She has become one of the world's leading epidemiologists and made major contributions to the global understanding of how HIV affects young women.
Limited health literacy can lead to difficulties in patients' self-care activities such as taking prescribed medications. Since a considerable amount of health information changes hands in the pharmacy setting, research by pharmacists into evaluating which tools are effective in practice can make a valuable contribution to goals set by the 2010 US National Action Plan to Improve Health Literacy and lead to improvements in communications and health care, say experts in this special themed issue on "Pharmacy, Medication Use, and the National Action Plan to Improve Health Literacy," published in the journal Research in Social and Administrative Pharmacy.
Artemisinin-based combination therapies (ACTs) are the currently recommended drugs for treating malaria. However, they are expensive, which limits their affordability. This means that people with malaria are likely to buy cheaper, less effective antimalarials such as chloroquine and sulphadoxine-pyrimethamine; or to simply buy painkillers and antipyretics.
› Verified 2 days ago
Sheila R Glaess, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 130 Fisher Rd, Mob-a Suite 1-4, Berlin, VT 05602 Phone: 802-371-5961 Fax: 802-371-5960 | |
Stephen J Woodruff, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 22 Eastview Lane, Berlin, VT 05641 Phone: 802-479-4006 | |
Gail Susan Yanowitch, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 130 Fisher Rd Ste 1-4, Cvmc Women's Health, Berlin, VT 05602 Phone: 802-371-5961 Fax: 802-371-5960 | |
Julie A Vogel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Suite 1-4, Berlin, VT 05602 Phone: 802-371-5961 Fax: 802-371-5960 | |
Priyanka Singh, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 130 Fisher Rd Ste 1-4, Cvmc Women's Health, Berlin, VT 05602 Phone: 802-371-5961 Fax: 802-371-5960 | |
Roger E Ehret, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 130 Fisher Rd, Mob-a Suite 1-4, Berlin, VT 05602 Phone: 802-371-5961 Fax: 802-371-5960 | |
Roger H Knowlton, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Mob-a Suite 1-4, Berlin, VT 05602 Phone: 802-371-5961 Fax: 802-371-5960 |